Viewing Study NCT00907894


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-27 @ 11:09 PM
Study NCT ID: NCT00907894
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2009-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module